1.  Brooks MB, Catalfamo JL. von Willebrand disease. Schalm’s veterinary hematology. 2022 Apr 22:731-8.
  2.  Genetic Home of Reference. Von Willebrand Disease. U.S. National Library of Medicine. Published 2020. Accessed June 15, 2020.
  3.  Von Willebrand Disease. National Hemophilia Foundation. Published 2020. Accessed June 15, 2020.
  4. ↑ Jump up to:4.0 4.1 4.2 Leebeek FWG, Eikenboom JCJ. Von Willebrand’s diseaseN Engl J Med. 2016;375(21):2067-2080.
  5. ↑ Jump up to:5.0 5.1 5.2 Rassoulzadegan M, Ala F, Jazebi M, et al. Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience. Int J Hematol. 2020;111(4):535-543.
  6. ↑ Jump up to:6.0 6.1 6.2 6.3 Randi AM, Laffan MA. Von Willebrand factor and angiogenesis: basic and applied issuesJ Thromb Haemost. 2017;15(1):13-20.
  7.  Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 2014;25(3):206-216.
  8.  Lenting PJ, Casari C, Christophe OD, Denis C V. von Willebrand factor: the old, the new and the unknownJ Thromb Haemost. 2012;10(12):2428-2437.
  9.  Kalot MA, Husainat N, El Alayli A, Abughanimeh O, Diab O, Tayiem S, Madoukh B, Dimassi AB, Qureini A, Ameer B, Eikenboom JC. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis. Blood advances. 2022 Jan 11;6(1):62-71.
  10.  Sharma R, Haberichter SL. New advances in the diagnosis of von Willebrand disease. Hematology. 2019;2019(1):596-600.
  11.  Echahdi H, El Hasbaoui B, El Khorassani M, Agadr A, Khattab M. Von Willebrand’s disease: case report and review of the literature. Pan Afr Med J. 2017;27:147.
  12. ↑ Jump up to:12.0 12.1 Nazzaro A-M, Philipp CS, Johnson RW, James AH. Von Willebrand Disease. National Organization of Rare Diseases… Published 2020. Accessed June 15, 2020.
  13.  Bharati KP, Prashanth UR. Von Willebrand disease: an overview. Indian J Pharm Sci. 2011;73(1):7-16.
  14.  Schiel, WC. Medical Definition of Autosomal Dominant. MedicineNet.
  15. ↑ Jump up to:15.0 15.1 15.2 15.3 15.4 Von Willebrand Disease. NHS. Published 2017. Accessed June 16, 2020.
  16. ↑ Jump up to:16.0 16.1 16.2 16.3 16.4 Types of von Willebrand disease. Canadian Hemophilia Society. Published 2018. Accessed June 16, 2020.
  17.  Vanduine S, Ridley K, Bashutski J, Snyder M, Powell C, Taichman S. Gingival bleeding and oral hygiene in women with von Willebrand Disease (VWD): a pilot study. J Haemoph Pract. 2018;4(1):49-57.
  18.  Hemophilia of Georgia. Types of von Willebrand Disease. The Hemophilia, von Willebrand Disease & Platelet Disorders Handbook. Published 2007. Accessed June 16, 2020.
  19.  Seidizadeh O, Peyvandi F, Mannucci PM. Von Willebrand disease type 2N: an update. Journal of Thrombosis and Haemostasis. 2021 Apr;19(4):909-16.
  20.  Pollak ES. Von Willebrand Disease Clinical Presentation. Medscape. Published 2019. Accessed June 16, 2020
  21.  Ichinose A, Osaki T, Souri M, Favaloro EJ. A review of autoimmune acquired von Willebrand factor deficiency in Japan. InSeminars in Thrombosis and Hemostasis 2022 Jul 8. Thieme Medical Publishers, Inc..
  22.  Sanders Y V, Fijnvandraat K, Boender J, et al. Bleeding spectrum in children with moderate or severe von Willebrand disease:  Relevance of pediatric-specific bleedingAm J Hematol. 2015;90(12):1142-1148.
  23.  Castaman G, Linari S. Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding DisordersJ Clin Med. 2017;6(4):45.
  24.  National Center on Birth Defects and Developmental Disabilities. von Willebrand Disease (VWD) Diagnosis. Centres for Disease Control and Prevention. Published 2019. Accessed June 17, 2020.
  25.  Roberts JC, Flood VH. Laboratory diagnosis of von Willebrand disease. Int J Lab Hematol. 2015;37(1):139-148.
  26. ↑ Jump up to:26.0 26.1 26.2 26.3 26.4 Ng C, Motto DG, Paola J Di. Diagnostic approach to von Willebrand disease. Blood. 2015;125(13):2029-2037. doi:10.1182/blood-2014-08-528398
  27. ↑ Jump up to:27.0 27.1 Chapin J. Von Willebrand disease in the elderly: clinical perspectivesClin Interv Aging. 2018;13:1531-1541.
  28. ↑ Jump up to:28.0 28.1 28.2 Sharma R, Flood VH. Advances in the diagnosis and treatment of Von Willebrand disease. Haematology. 2017 Dec 8;2017(1):379-84.
  29.  Green D. Diagnosis and Treatment of von Willebrand Disease. NEJM Jornal Watch. Published 2017. Accessed June 17, 2020.
  30. ↑ Jump up to:30.0 30.1 Lowes LP, Alfano L, Orlin MN. Musculoskeletal System: Considerations and Interventions for Specific Pediatric Pathology. In: Effgen SK, ed. Meeting the Physical Therapy Needs of Children. 2nd ed. Philadelphia: F. A. Davis Company; 2013:226-227.
  31. ↑ Jump up to:31.0 31.1 Medical and Scientific Advisory Council. Physical Therapy Evaluation Recommendations. Natl Hemoph Found. 2018.
  32.  National Hemophilia Foundation. Physical Therapy Practice Guidelines for Persons with Bleeding Disorders: Muscle Bleed. 2018;